The groundbreaking approach of tirzepatide peptide represents a significant development in the handling of the condition. Unlike existing therapies, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone – resulting in improved glucose regulation and possible